1. Bluesky Feeds /
  2. Buck Samuel πŸͺ±πŸ¦ πŸ§¬πŸ”¬ /
  3. Host-Microbe

Feed of host-microbe or host-microbiome mentions over the past 7 days.

Feed on Bluesky

Feeds Stats

  • πŸ’™ Liked by 2 users
  • πŸ“… Updated 11 months ago
  • βš™οΈ Provider skyfeed.me

Host-Microbe Likes over time

Like count prediction
The feed Host-Microbe has not gained any likes in the last month.

Feed Preview for Host-Microbe

i3S - Institute for Research and Innovation in Health | UPorto
@i3suporto.bsky.social
1 day ago
EVENTS III ImmunoHUB Annual Meeting The Microbe-Host Interface: Interactions and Evolution ⚠️ Abstract submission until 17 October πŸ“…5 December 2025 πŸ“#i3S ⏰Registration deadline: November 7th βž•info: lnkd.in/d8uY-BF3 #i3Sevents #ERAChairs #ImmunoHUB #EUfunding
0
0
0
Shicheng Guo
@shihcheng.bsky.social
2 days ago
Discover uMetaP: 5000x better metaproteome analysis! Unveil host-microbiome interactions & drug targets with high-sensitivity LC-MS and novoMP sequencing. PMID:40681571, Nat Commun 2025, @NatureComms doi.org/10.1038/s41467-02… #Medsky #Pharmsky #RNA #ASHG #ESHG πŸ§ͺ
Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseases | Nature Communications

doi.org

Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseases | Nature Communications

The functional characterization of host-gut microbiome interactions remains limited by the sensitivity of current metaproteomic approaches. Here, we present uMetaP, an ultra-sensitive workflow combining advanced LC-MS technologies with an FDR-validated de novo sequencing strategy, novoMP. uMetaP markedly expands functional coverage and improves the taxonomic detection limit of the gut dark metaproteome by 5000-fold, enabling precise detection and quantification of low-abundance microbial and host proteins. Applied to a mouse model of intestinal injury, uMetaP revealed host-microbiome functional networks underlying tissue damage, beyond genomic findings. Orthogonal validation using transcriptomic data from Crohn’s disease patients confirmed key host protein alterations. Furthermore, we introduce the concept of a druggable metaproteome, mapping functional targets within the host and microbiota. By redefining the sensitivity limits of metaproteomics, uMetaP provides a highly valuable fram

0
2
5